FasL, leukocytes and vascular modeling - Reply

被引：2

作者：

Ishida, S ^{[1
]}

Yamashiro, K

Usui, T

Adamis, AP

机构：

[1] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Angiogenesis Lab,Retina Res Lab, Boston, MA 02114 USA

[2] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 108, Japan

[3] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan

[4] Univ Tokyo, Fac Med, Dept Ophthalmol, Tokyo, Japan

[5] Eyetech Pharmaceut, Eyetech Res Ctr, Woburn, MA 01801 USA

来源：

NATURE MEDICINE | 2004年 / 10卷 / 01期

关键词：

D O I：

10.1038/nm0104-13

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：13 / 13

页数：1

共 6 条

[1] The role of Fas-FasL in the development and treatment of ischemic retinopathy [J].

Barreiro, R ;

Schadlu, R ;

Herndon, J ;

Kaplan, HJ ;

Ferguson, TA .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (03) :1282-1286

[2] Increased retinal neovascularization in Fas ligand-deficient mice [J].

Davies, MH ;

Eubanks, JP ;

Powers, MR .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (07) :3202-3210

[3] VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization [J].

Ishida, S ;

Usui, T ;

Yamashiro, K ;

Kaji, Y ;

Amano, S ;

Ogura, Y ;

Hida, T ;

Oguchi, Y ;

Ambati, J ;

Miller, JW ;

Gragoudas, ES ;

Ng, YS ;

D'Amore, PA ;

Shima, DT ;

Adamis, AP .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (03) :483-489

[4] Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease [J].

Ishida, S ;

Yamashiro, K ;

Usui, T ;

Kaji, Y ;

Ogura, Y ;

Hida, T ;

Honda, Y ;

Oguchi, Y ;

Adamis, AP .

NATURE MEDICINE, 2003, 9 (06) :781-788

[5] Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP [J].

Sata, M ;

Walsh, K .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) :33103-33106

[6] Oxidized LDL activates Fas-mediated endothelial cell apoptosis [J].

Sata, M ;

Walsh, K .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (09) :1682-1689

← 1 →